News

Fierce Pharma4d
Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks
Merck KGaA’s long courtship of SpringWorks Therapeutics has come to fruition as the German drugmaker has bought out the ...
The Global Legal Post2d
Sullivan & Cromwell, Goodwin Procter guide Merck’s $3.9bn US biotech buy
Sullivan & Cromwell is acting for longtime client Merck in its $3.9bn acquisition of US biotech company SpringWorks ...